Ayala I, Castillo A M, Adánez G, Fernández-Rufete A, Pérez B G, Castells M T. 2009. Hyperlipidemic chicken as a model of non-alcoholic steatohepatitis. Experimental Biology and Medicine, 234, 10–16.
Bannister D W, Evans A J, Whitehead C C. 1975. Evidence for a lesion in carbohydrate metabolism in fatty liver and kidney syndrome in chicks. Research in Veterinary Science, 18, 149–156.
Bao S, Wu Y L, Wang X, Han S, Cho S, Ao W, Nan J X. 2020. Agriophyllum oligosaccharides ameliorate hepatic injury in type 2 diabetic db/db mice targeting INS-R/IRS-2/PI3K/AKT/PPAR-γ/Glut4 signal pathway. Journal of Ethnopharmacology, 257, 112863.
Benito-Vicente A, Uribe K B, Rotllan N, Ramírez C M, Jebari-Benslaiman S, Goedeke L, Canfrán-Duque A, Galicia-García U, Saenz De Urturi D, Aspichueta P, Suárez Y, Fernández-Hernando C, Martín C. 2020. miR-27b Modulates insulin signaling in hepatocytes by regulating insulin receptor expression. International Journal of Molecular Sciences, 21, 8675.
Bensadoun A, Rothfeld A. 1972. The form of absorption of lipids in the chicken, Gallus domesticus. In: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine, New York. pp. 814–817.
Cai Y, Song Z, Zhang X, Wang X, Jiao H, Lin H. 2009. Increased de novo lipogenesis in liver contributes to the augmented fat deposition in dexamethasone exposed broiler chickens (Gallus gallus domesticus). Comparative Biochemistry and Physiology (C: Toxicology & Pharmacology), 150, 164–169.
Castro R E, Ferreira D M, Afonso M B, Borralho P M, Machado M V, Cortez-Pinto H, Rodrigues C M. 2013. MiR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease. Journal of Hepatology, 58, 119–125.
Cherian G, Goeger M P. 2004. Hepatic lipid characteristics and histopathology of laying hens fed CLA or n-3 fatty acids. Lipids, 39, 31–36.
Choudhari S K, Chaudhary M, Gadbail A R, Sharma A, Tekade S. 2014. Oxidative and antioxidative mechanisms in oral cancer and precancer: A review. Oral Oncology, 50, 10–18.
Clarke S D, Jump D. 2018. Regulation of hepatic gene expression by dietary fats: A unique role for polyunsaturated fatty acids. In: Nutrition and Gene Expression. Taylor & Francis Group Country, London. pp. 227–246.
Day C P, James O F. 1998. Steatohepatitis: a tale of two “hits”? Gastroenterology, 114, 842–845.
Eckstein S S, Weigert C, Lehmann R. 2017. Divergent roles of IRS (Insulin Receptor Substrate) 1 and 2 in liver and skeletal muscle. Current Medicinal Chemistry, 24, 1827–1852.
Feng Z, Li Z, Zhu D, Ling W, Zheng L, Pu L, Kong L. 2017. Mir-24 regulates hepatocyte apoptosis via BIM during acute liver failure. American Journal of Translational Research, 9, 4925–4935.
Ferreira D M, Afonso M B, Rodrigues P M, Simão A L, Pereira D M, Borralho P M, Rodrigues C M, Castro R E. 2014. C-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver. Molecular and Cellular Biology, 34, 1100–1120.
Fraslin J M, Touquette L, Douaire M, Menezo Y, Guillemot J C, Mallard J. 1992. Isolation and long-term maintenance of differentiated adult chicken hepatocytes in primary culture. In Vitro Cellular & Developmental Biology, 28a, 615–620.
Giordano S, Columbano A. 2013. MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? Hepatology, 57, 840–847.
He Y, Hwang S, Cai Y, Kim S J, Xu M, Yang D, Guillot A, Feng D, Seo W, Hou X, Gao B. 2019. MicroRNA-223 Ameliorates nonalcoholic steatohepatitis and cancer by targeting multiple inflammatory and oncogenic genes in hepatocytes. Hepatology, 70, 1150–1167.
Ke F, Ren C, Zhai Z, Gao X, Wei J, Zhu Y, Zhi Y. 2022. LINC01234 regulates microRNA-27b-5p to induce the migration, invasion and self-renewal of ovarian cancer stem cells through targeting SIRT5. Cell Cycle, 21, 1020–1033.
Kubota N, Kubota T, Itoh S, Kumagai H, Kozono H, Takamoto I, Mineyama T, Ogata H, Tokuyama K, Ohsugi M, Sasako T, Moroi M, Sugi K, Kakuta S, Iwakura Y, Noda T, Ohnishi S, Nagai R, Tobe K, Terauchi Y, Ueki K, Kadowaki T. 2008. Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding. Cell Metabolism, 8, 49–64.
Liu T, Yang T, Xu Z, Tan S, Pan T, Wan N, Li S. 2018. MicroRNA-193b-3p regulates hepatocyte apoptosis in selenium-deficient broilers by targeting MAML1. Journal of Inorganic Biochemistry, 186, 235–245.
Nassir F, Adewole O L, Brunt E M, Abumrad N A. 2013. CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice. Journal of Lipid Research, 54, 2988–2997.
Pierantonelli I, Svegliati-Baroni G. 2019. Nonalcoholic fatty liver disease: Basic pathogenetic mechanisms in the progression from NAFLD to NASH. Transplantation, 103, e1–e13.
Shan W, Gao L, Zeng W, Hu Y, Wang G, Li M, Zhou J, Ma X, Tian X, Yao J. 2015. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease. Cell Death & Disease, 6, e1833.
Shini A, Shini S, Bryden W L. 2019. Fatty liver haemorrhagic syndrome occurrence in laying hens: impact of production system. Avian Pathology, 48, 25–34.
Singaravelu R, Chen R, Lyn R K, Jones D M, O’Hara S, Rouleau Y, Cheng J, Srinivasan P, Nasheri N, Russell R S, Tyrrell D L, Pezacki J P. 2014. Hepatitis C virus induced up-regulation of microRNA-27: A novel mechanism for hepatic steatosis. Hepatology, 59, 98–108.
Tachibana S, Sato K, Takahashi T, Akiba Y. 2002. Octanoate inhibits very low-density lipoprotein secretion in primary cultures of chicken hepatocytes. Comparative Biochemistry and Physiology, 132, 621–627.
Teimouri M, Hosseini H, Shabani M, Koushki M, Noorbakhsh F, Meshkani R. 2020. Inhibiting miR-27a and miR-142-5p attenuate nonalcoholic fatty liver disease by regulating Nrf2 signaling pathway. IUBMB Life, 72, 361–372.
Thirone A C, Huang C, Klip A. 2006. Tissue-specific roles of IRS proteins in insulin signaling and glucose transport. Trends in Endocrinology and Metabolism, 17, 72–78.
Tian W H, Wang Z, Yue Y X, Li H, Li Z J, Han R L, Tian Y D, Kang X T, Liu X J. 2019. MiR-34a-5p increases hepatic triglycerides and total cholesterol levels by regulating ACSL1 protein expression in laying hens. International Journal of Molecular Sciences, 20, 4420.
Trott K A, Giannitti F, Rimoldi G, Hill A, Woods L, Barr B, Anderson M, Mete A. 2014. Fatty liver hemorrhagic syndrome in the backyard chicken: A retrospective histopathologic case series. Veterinary Pathology, 51, 787–795.
Verma S, Mishra R, Malik A, Chaudhary P, Malhotra S S, Panda A K, Gupta S K. 2021. MiR-27b-5p inhibits BeWo cells fusion by regulating WNT2B and enzyme involved in progesterone synthesis. American Journal of Reproductive Immunology, 86, e13409.
Vickers K C, Shoucri B M, Levin M G, Wu H, Pearson D S, Osei-Hwedieh D, Collins F S, Remaley A T, Sethupathy P. 2013. MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia. Hepatology, 57, 533–542.
Videla L A, Rodrigo R, Orellana M, Fernandez V, Tapia G, Quiñones L, Varela N, Contreras J, Lazarte R, Csendes A, Rojas J, Maluenda F, Burdiles P, Diaz J C, Smok G, Thielemann L, Poniachik J. 2004. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clinical Science, 106, 261–268.
Wang X, He Y, Mackowiak B, Gao B. 2021. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. Gut, 70, 784–795.
Xu H, Zhou Y, Liu Y, Ping J, Shou Q, Chen F, Ruo R. 2016. Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis. The Journal of Endocrinology, 229, 133–144.
Xu Y, Li Z, Zhang S, Zhang H, Teng X. 2020. MiR-187-5p/apaf-1 axis was involved in oxidative stress-mediated apoptosis caused by ammonia via mitochondrial pathway in chicken livers. Toxicology and Applied Pharmacology, 388, 114869.
Yang P, Liang Y, Luo Y, Li Z, Wen Y, Shen J, Li R, Zheng H, Gu H F, Xia N. 2019. Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway. Diabetes, Metabolic Syndrome and Obesity (Targets and Therapy), 12, 1013–1021.
Yilmaz Y, Younossi Z M. 2014. Obesity-associated nonalcoholic fatty liver disease. Clinics in Liver Disease, 18, 19–31.
You X, Liu F, Zhang T, Li Y, Ye L, Zhang X. 2013. Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells. Carcinogenesis, 34, 1644–1652.
Zhang Y, Liu Z, Liu R, Wang J, Zheng M, Li Q, Cui H, Zhao G, Wen J. 2018. Alteration of hepatic gene expression along with the inherited phenotype of acquired fatty liver in chicken. Genes, 9, 199.
Zhang Y, Wang C, Lu J, Jin Y, Xu C, Meng Q, Liu Q, Dong D, Ma X, Liu K, Sun H. 2020. Targeting of miR-96-5p by catalpol ameliorates oxidative stress and hepatic steatosis in LDLr–/– mice via p66shc/cytochrome C cascade. Aging, 12, 2049–2069.
Zhao J, Zhao X, Shen X, Zhang Y, Zhang Y, Ye L, Li D, Zhu Q, Yin H. 2022. CircCCDC91 regulates chicken skeletal muscle development by sponging miR-15 family via activating IGF1-PI3K/AKT signaling pathway. Poultry Science, 101, 101803.
|